W.H.O. approves China's Sinopharm vaccine for emergency use.
Source: New York Times
The World Health Organization on Friday approved Chinas Sinopharms Covid-19 vaccine for emergency use, easing the way for poorer nations to get access to another much-needed shot to help end the pandemic. The approval allows the Sinopharm vaccine to be included in Covax, the World Health Organizations global initiative that is designed to promote equitable vaccine distribution around the world. The need is dire.
Rich countries are hoarding doses. India, a major vaccine maker, has stopped exports to address its worsening coronavirus crisis. Questions about safety after exceedingly rare side effects led some countries to briefly pause using AstraZeneca and Johnson & Johnson doses or change their guidance around the use.
Reliable vaccine access could improve further next week when the W.H.O. considers another Chinese shot, made by the company Sinovac. Andrea Taylor, who analyzes global data on vaccines at the Duke Global Health Institute, called the potential addition of two Chinese vaccines into the Covax program a game changer.
The situation right now is just so desperate for low- and lower-middle-income countries that any doses we can get out are worth mobilizing, Ms. Taylor said. Having potentially two options coming from China could really change the landscape of whats possible over the next few months.
Read more: https://www.nytimes.com/2021/05/07/world/who-covid-sinopharm-vaccine.html